COVID-19 (severe/critical) |
Patient characteristics |
Smoking [History of smoking vs. Non smoking] |
Odds ratio: 1.910 (1.420-2.590)
|
Patanavanich
|
|
|
COVID-19 (severe/critical) |
Findings |
Radiological finding - Chest CT scan [subsegmental areas of consolidation vs. Not applicable] |
Odds ratio: 0.202 (0.062-0.659)
§ |
Tang
|
|
|
COVID-19 (severe/critical) |
Findings |
Radiological finding - Chest CT scan [Bilateral patchy areas of GGO vs. Not applicable] |
Odds ratio: 11.628 (2.028-66.667)
§ |
Tang
|
|
|
COVID-19 (severe/critical) |
Laboratory Findings |
LDH [1 unit increase vs. Not applicable] |
Odds ratio: 0.993 (0.986-1.000)
§ |
Tang
|
|
|
COVID-19 (severe/critical) |
Laboratory Findings |
AST [1 unit increase vs. Not applicable] |
Odds ratio: 0.979 (0.957-1.002)
§ |
Tang
|
|
|
COVID-19 (severe/critical) |
Laboratory Findings |
PT [1 unit increase vs. Not applicable] |
Odds ratio: 1.595 (1.165-2.183)
§ |
Tang
|
|
|
COVID-19 (severe/critical) |
Symptoms |
Myalgia/Arthralgia [Present vs. Not present] |
Odds ratio: 0.546 (0.153-1.953)
§ |
Tang
|
|
|
COVID-19 (severe/critical) |
Symptoms |
Gastrointestinal symptoms [Present vs. Not present] |
Odds ratio: 10.000 (0.900-111.111)
§ |
Tang
|
|
|
COVID-19 (severe/critical) |
Symptoms |
Sputum [Present vs. Not present] |
Odds ratio: 0.104 (0.019-0.578)
§ |
Tang
|
|
|
COVID-19 (severe/critical) |
Symptoms |
Fatigue [Present vs. Not present] |
Odds ratio: 8.547 (1.534-47.619)
§ |
Tang
|
|
|
COVID-19 (severe/critical) |
Complications |
APACHE II score [1 unit increase vs. Not applicable] |
Odds ratio: 0.890 (0.738-1.073)
§ |
Tang
|
|
|
COVID-19 (severe/critical) |
Complications |
Sequential Organ Failure Assessment (SOFA) score [1 unit increase vs. Not applicable] |
Odds ratio: 0.442 (0.219-0.890)
§ |
Tang
|
|
|
COVID-19 (severe/critical) |
Comorbidities |
Cardiovascular disease [Present vs. Not present] |
Odds ratio: 1.585 (0.208-12.048)
§ |
Tang
|
|
|
COVID-19 (severe/critical) |
Patient characteristics |
Age [1 year increase vs. Not applicable] |
Odds ratio: 1.101 (1.022-1.186)
§ |
Tang
|
|
|
COVID-19 (death) |
Comorbidities |
Cardiovascular disease [Present vs. Not present] |
Odds ratio: 11.080 (2.590-47.320)
|
Aggarwal
|
|
|
COVID-19 (severe/critical) |
Comorbidities |
Cardiovascular disease [Present vs. Not present] |
Odds ratio: 3.140 (2.320-4.240)
|
Aggarwal
|
|
|
COVID-19 in children (severe/critical) |
Comorbidities |
Any comorbidity [Present vs. Not present] |
Odds ratio: 3.270 (1.670-6.420)
§ |
Götzinger
|
|
|
COVID-19 in children (severe/critical) |
Symptoms |
Lower respiratory tract infection [Present vs. Not present] |
Odds ratio: 10.460 (5.160-21.230)
§ |
Götzinger
|
|
|
COVID-19 in children (severe/critical) |
Patient characteristics |
Gender [Male vs. Female] |
Odds ratio: 2.120 (1.060-4.210)
§ |
Götzinger
|
|
|
COVID-19 in children (severe/critical) |
Patient characteristics |
Age [>1 month vs. <=1 month] |
Odds ratio: 5.060 (1.720-14.870)
|
Götzinger
|
|
|
COVID-19 in children (severe/critical) |
Patient characteristics |
Age [1 year increase vs. Not applicable] |
Odds ratio: 0.900 (0.900-1.000)
|
Götzinger
|
|
|
COVID-19 (death) |
Laboratory Findings |
Creatinine [missing vs. 0-1.1] |
Hazard ratio: 1.480 (0.560-3.900)
§ |
Petrilli
|
|
|
COVID-19 (death) |
Laboratory Findings |
Creatinine [>2 vs. 0-1.1] |
Hazard ratio: 1.490 (1.080-2.040)
§ |
Petrilli
|
|
|
COVID-19 (death) |
Laboratory Findings |
Creatinine [>1.1-2 vs. 0-1.1] |
Hazard ratio: 1.360 (1.110-1.680)
§ |
Petrilli
|
|
|
COVID-19 (death) |
Laboratory Findings |
Lymphocyte count [missing vs. >1.2] |
Hazard ratio: 2.160 (1.090-4.270)
§ |
Petrilli
|
|
|
COVID-19 (death) |
Laboratory Findings |
Lymphocyte count [<0.5 vs. >1.2] |
Hazard ratio: 1.380 (1.050-1.810)
§ |
Petrilli
|
|
|
COVID-19 (death) |
Laboratory Findings |
Lymphocyte count [0.5-0.8 vs. >1.2] |
Hazard ratio: 1.040 (0.840-1.280)
§ |
Petrilli
|
|
|
COVID-19 (death) |
Laboratory Findings |
Lymphocyte count [0.8-1.2 vs. >1.2] |
Hazard ratio: 0.890 (0.700-1.140)
§ |
Petrilli
|
|
|
COVID-19 (death) |
Vital Signs |
Oxygen saturation [missing vs. >92] |
Hazard ratio: 1.030 (0.620-1.710)
§ |
Petrilli
|
|
|
COVID-19 (death) |
Vital Signs |
Oxygen saturation [<88 vs. >92] |
Hazard ratio: 2.000 (1.610-2.480)
§ |
Petrilli
|
|
|
COVID-19 (death) |
Vital Signs |
Oxygen saturation [88-92 vs. >92] |
Hazard ratio: 1.460 (1.180-1.790)
§ |
Petrilli
|
|
|
COVID-19 (death) |
Symptoms |
Body temperature [>39 vs. <38] |
Hazard ratio: 1.040 (0.790-1.370)
§ |
Petrilli
|
|
|
COVID-19 (death) |
Symptoms |
Body temperature [38-39 vs. <38] |
Hazard ratio: 1.170 (0.960-1.430)
§ |
Petrilli
|
|
|
COVID-19 (death) |
Comorbidities |
Cancer [Present vs. Not present] |
Hazard ratio: 1.290 (1.030-1.620)
§ |
Petrilli
|
|
|
COVID-19 (death) |
Comorbidities |
Chronic kidney disease [Present vs. Not present] |
Hazard ratio: 0.920 (0.730-1.160)
§ |
Petrilli
|
|
|
COVID-19 (death) |
Comorbidities |
Asthma or COPD [Present vs. Not present] |
Hazard ratio: 1.030 (0.830-1.290)
§ |
Petrilli
|
|
|
COVID-19 (death) |
Comorbidities |
Diabetes [Present vs. Not present] |
Hazard ratio: 1.010 (0.850-1.210)
§ |
Petrilli
|
|
|
COVID-19 (death) |
Comorbidities |
Hypertension [Present vs. Not present] |
Hazard ratio: 0.980 (0.780-1.230)
§ |
Petrilli
|
|
|
COVID-19 (death) |
Comorbidities |
Hyperlipidaemia [Present vs. Not present] |
Hazard ratio: 0.980 (0.820-1.170)
§ |
Petrilli
|
|
|
COVID-19 (death) |
Comorbidities |
Heart failure [Present vs. Not present] |
Hazard ratio: 1.540 (1.230-1.930)
§ |
Petrilli
|
|
|
COVID-19 (death) |
Comorbidities |
Coronary artery disease [Present vs. Not present] |
Hazard ratio: 1.100 (0.900-1.350)
§ |
Petrilli
|
|
|
COVID-19 (severe/fatal) |
Findings |
Radiological finding during hospitalization [CT-SS>14 vs. Normal] |
Hazard ratio: 1.946 (1.095-3.459)
§ |
Xu
|
|
|
COVID-19 (severe/fatal) |
Complications |
Lymphopenia [Present vs. Not present] |
Hazard ratio: 3.014 (1.356-6.697)
§ |
Xu
|
|
|
COVID-19 (severe/fatal) |
Complications |
Leukocytosis [Present vs. Not present] |
Hazard ratio: 6.349 (3.330-12.108)
§ |
Xu
|
|
|
COVID-19 (severe/fatal) |
Comorbidities |
>=2 comorbidities [Present vs. Not present] |
Hazard ratio: 4.778 (2.451-9.315)
§ |
Xu
|
|
|
COVID-19 (death) |
Findings |
Radiological finding during hospitalization [CT-SS>14 vs. Normal] |
Hazard ratio: 2.915 (1.376-6.177)
§ |
Xu
|
|
|
COVID-19 (death) |
Complications |
Lymphopenia [Present vs. Not present] |
Hazard ratio: 4.579 (1.334-15.715)
§ |
Xu
|
|
|
COVID-19 (death) |
Complications |
Leukocytosis [Present vs. Not present] |
Hazard ratio: 9.639 (4.572-20.321)
§ |
Xu
|
|
|
COVID-19 (severe/fatal) |
Patient characteristics |
Age [>60 years vs. <=60 years] |
Hazard ratio: 2.231 (1.124-4.427)
§ |
Xu
|
|
|
COVID-19 (death) |
Comorbidities |
>=2 comorbidities [Present vs. Not present] |
Hazard ratio: 6.734 (3.239-14.003)
§ |
Xu
|
|
|